Our Pricing

What Countries Is Mounjaro Available In: Global Availability and UK Access

Published: 11 September 2026

Understanding what countries is Mounjaro available in helps patients navigate global access to this breakthrough tirzepatide treatment for type 2 diabetes and weight management. Since its initial approval by the US FDA in May 2022, Mounjaro has expanded to multiple markets worldwide, including the UK where it received MHRA approval in September 2022 [1]. As a UK-registered pharmacy, we provide access to genuine Mounjaro following clinical assessment by our prescribers, with transparent pricing from £124.99.

What Countries Is Mounjaro Available In: Regulatory Approval Status

When examining what countries is Mounjaro available in, the United States led global approvals with FDA authorisation in May 2022 for type 2 diabetes management [1]. The European Medicines Agency (EMA) followed with approval across all 27 EU member states in September 2022, making tirzepatide accessible throughout the European Union under the brand name Mounjaro [2].

The UK's Medicines and Healthcare products Regulatory Agency (MHRA) granted marketing authorisation for Mounjaro in September 2022, enabling prescribing for adults with type 2 diabetes as monotherapy or combination therapy [1]. Beyond Europe and North America, Mounjaro has received regulatory approval in Japan, Australia, Canada, and the United Arab Emirates, with ongoing submissions in numerous other markets including several Asian and Latin American countries [2].

In clinical practice at Cured Pharmacy, we've observed increasing patient enquiries about international availability, particularly from individuals travelling abroad or relocating. Our superintendent pharmacist Tarun Kumar emphasises that whilst Mounjaro is approved in multiple countries, prescriptions and supply must comply with UK regulations for patients based here, ensuring continuity of care and medication authenticity.

Mounjaro Availability in European Countries Beyond the UK

Addressing what countries is Mounjaro available in across Europe reveals comprehensive access following EMA approval. All 27 EU member states can prescribe Mounjaro, including Germany, France, Spain, Italy, the Netherlands, Belgium, Sweden, Denmark, Poland, and Ireland [2]. Each country manages its own reimbursement and pricing structures, meaning out-of-pocket costs vary significantly between markets.

Switzerland, whilst not an EU member, approved Mounjaro through Swissmedic in late 2022, and Norway granted approval through its national medicines agency. The European rollout prioritised type 2 diabetes indications initially, with weight management indications following regulatory pathways separately in each jurisdiction [2]. Patients travelling within Europe should consult local healthcare providers about prescription recognition and pharmacy access.

UK-Specific Mounjaro Access and Prescribing

In the UK specifically, Mounjaro is available through both NHS and private prescribing routes, though NHS access remains limited by NICE guidance criteria focusing on specific patient populations with type 2 diabetes [3]. Private prescribing, as offered through Cured Pharmacy, provides broader access following comprehensive clinical assessment by UK-registered prescribers, with treatment available from £124.99 subject to medical suitability.

Our online consultation process takes under three minutes and ensures every patient receives individualised prescriber review before dispensing. We supply only genuine UK-licensed Mounjaro manufactured by Eli Lilly, delivered in discreet packaging with full patient information leaflets and support from our GPhC-registered pharmacy team.

What Countries Is Mounjaro Available In: North America and Asia-Pacific

Examining what countries is Mounjaro available in beyond Europe, the United States maintains the most established market access, with widespread insurance coverage and pharmacy availability since the 2022 FDA approval [1]. Canada approved Mounjaro through Health Canada in 2023, making tirzepatide accessible to Canadian patients with type 2 diabetes through prescription.

In the Asia-Pacific region, Japan's Pharmaceuticals and Medical Devices Agency (PMDA) approved Mounjaro in 2023, whilst Australia's Therapeutic Goods Administration (TGA) granted approval in late 2022 [2]. These approvals enable prescribing across major developed markets, though each country maintains distinct clinical guidelines and reimbursement criteria. Emerging markets including South Korea, Taiwan, and Singapore have regulatory submissions under review, with approvals anticipated throughout 2024-2025.

Global Supply Considerations and Patient Safety

Understanding what countries is Mounjaro available in matters critically for patient safety, as counterfeit tirzepatide products have emerged in markets without regulatory approval. Patients should only obtain Mounjaro through licensed pharmacies in approved countries, avoiding online vendors claiming to supply to non-approved markets [4]. At Cured Pharmacy, we verify every supply chain step, ensuring medicines originate from UK-licensed wholesalers and meet MHRA standards.

For UK patients travelling internationally, we recommend discussing travel plans with prescribers to ensure adequate supply and proper storage during transit. Mounjaro requires refrigeration between 2-8°C until first use, making international travel logistics important to maintain medication efficacy [1].

Clinical Evidence Supporting Mounjaro Availability Worldwide

The question of what countries is Mounjaro available in connects directly to the robust clinical evidence from the SURPASS trial programme, which enrolled over 10,000 participants globally and demonstrated superior glycaemic control compared to existing diabetes treatments [3]. SURPASS-2 showed that tirzepatide 15mg achieved HbA1c reductions of up to 2.46% compared to 1.86% with semaglutide 1mg, supporting regulatory approvals across multiple jurisdictions [3].

Weight loss outcomes from the SURPASS trials also influenced approval decisions, with participants achieving average weight reductions of 11.2kg on the 15mg dose over 40 weeks [3]. These consistent results across diverse patient populations in North America, Europe, Asia, and Latin America provided regulators worldwide with confidence in tirzepatide's efficacy and safety profile, facilitating broader market access.

The SURMOUNT clinical trial programme further examined tirzepatide specifically for weight management in adults without diabetes, demonstrating average weight loss of up to 20.9% with the 15mg dose over 72 weeks [4]. These findings have supported additional regulatory submissions for obesity indications in countries where Mounjaro is already approved for type 2 diabetes.

How to Access Mounjaro in Countries Where It Is Available

For patients researching what countries is Mounjaro available in with intent to access treatment, the process varies by healthcare system. In the UK, private access through registered online pharmacies like Cured Pharmacy offers the most straightforward route, requiring completion of a clinical questionnaire reviewed by UK prescribers within hours [1]. Our transparent pricing structure shows costs upfront before consultation, with Mounjaro available from £124.99 and an additional £20 off first orders using code Weightlossnew.

NHS access in the UK requires meeting specific NICE criteria, typically involving BMI thresholds, type 2 diabetes diagnosis, and previous treatment attempts [3]. Private prescribing removes these restrictions whilst maintaining rigorous clinical assessment standards, ensuring treatment suitability based on individual medical history, contraindications, and concurrent medications.

In other countries where Mounjaro is available, patients should consult local healthcare providers or licensed pharmacies to understand national prescribing protocols, insurance coverage, and cost structures. We advise against attempting to import Mounjaro from non-approved markets or through unlicensed suppliers, as medication authenticity and storage conditions cannot be verified, posing significant safety risks [4].

Cured Pharmacy's Role in UK Mounjaro Access

As a GPhC-registered pharmacy (9012511) under superintendent pharmacist Tarun Kumar (GPhC 2233073), Cured Pharmacy provides legitimate UK access to Mounjaro following the same regulatory standards as traditional pharmacies. Our clinical team includes UK-registered prescribers who assess every patient individually, ensuring treatment appropriateness and safety before dispensing. We supply only genuine UK-licensed Mounjaro with full traceability, delivered in discreet packaging with comprehensive patient support.

Our commitment to transparent pricing means patients see exact costs before starting consultation, with no hidden fees or surprise charges. For those researching what countries is Mounjaro available in and seeking UK access, our service combines clinical rigour with convenience, offering a trusted alternative to navigating NHS waiting lists or unclear pricing structures elsewhere.

Future Expansion: What Countries Is Mounjaro Available In Next

Looking forward at what countries is Mounjaro available in, regulatory submissions remain active in over 30 additional markets globally, including major economies in Latin America, the Middle East, and Southeast Asia [2]. Eli Lilly has indicated priority focus on countries with high type 2 diabetes prevalence and established regulatory frameworks for novel diabetes medications.

The World Health Organization estimates that over 420 million adults worldwide have diabetes, with prevalence increasing fastest in low- and middle-income countries [4]. Expanding Mounjaro availability to these markets depends on regulatory capacity, healthcare infrastructure, and pricing negotiations to ensure affordability. Some countries may approve tirzepatide under different brand names or through expedited pathways for medicines addressing significant unmet medical needs.

In the UK, ongoing NICE evaluations may expand NHS access criteria over time as real-world evidence accumulates and supply constraints ease. For now, private prescribing through registered pharmacies like Cured Pharmacy ensures patients can access Mounjaro based on clinical suitability rather than restrictive eligibility criteria, with prescriber oversight maintaining safety standards equivalent to NHS care.

Scientific References

1. Medicines and Healthcare products Regulatory Agency. (2022). Mounjaro 2.5 mg solution for injection in pre-filled pen: UK Public Assessment Report. MHRA. [accessed 11 September 2026]
2. European Medicines Agency. (2022). Mounjaro (tirzepatide): EU/1/22/1681/001-011. European Public Assessment Report. EMA. [accessed 11 September 2026]
3. Frías, J. P., Davies, M. J., Rosenstock, J., et al. (2021). Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes (SURPASS-2): a randomised, open-label, phase 3 trial. The Lancet, 398(10295), 143-155. [accessed 11 September 2026]
4. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide once weekly for the treatment of obesity. New England Journal of Medicine, 387(3), 205-216. [accessed 11 September 2026]
5. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 11 September 2026.
6. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 11 September 2026.
7. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 11 September 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.